FDA Approves New Eye Pressure Drop Formulation

WASHINGTON (MedPage Today) — The FDA approved a new formulation of the bimatoprost (Lumigan) in a 0.01% solution as a first-line treatment to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.


Read more

Related posts

Leave a Reply